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lar role in the regulation of tumor cell proliferation and
tumor surveillance.9 Immunohistochemical staining
with a monoclonal antigen for surface marker IOT-10
(CD57) provides a sensitive means for the identification
of NK cells in paraffin-embedded specimens.10
By using the monoclonal antibody for CD57, we
therefore investigated how the NK infiltration is related
to the regulation of tumor progression and prognosis in
a series of 150 cases of curatively resected pulmonary
adenocarcinoma.
Methods
Patients. Tissue specimens from 150 patients who under-
went curative pulmonary adenocarcinoma resection at the
First Department of Surgery, Teikyo University, between 1989
and 1994 were studied. Patients who died within 1 month
after the operation and those who underwent exploratory tho-
racotomy were excluded from the present study. Patients with
a history of another cancer were also excluded.
The lesions of these 150 patients were staged on both the
operative and pathologic findings according to the
International Union Against Cancer (UICC) TNM classifica-
tion.11 The histologic subtypes of adenocarcinoma were eval-
uated according to 1997 World Health Organization criteria.
The incidence of pulmonary adenocarcinoma isincreasing globally, and this condition is the most
common histologic type in the United States and
Japan.1,2 However, the behavior of pulmonary adenocar-
cinomas is not well understood. The results of the treat-
ment of pulmonary adenocarcinomas with surgery, other
therapies, or both remain unsatisfactory, and even for
those tumors classified as stage I, treatment fails in 30%
of patients with stage I adenocarcinoma.2 Therefore,
there is a need to identify new biologic markers as prog-
nostic indicators in pulmonary adenocarcinoma.
Tumor-infiltrating lymphocytes of tumors have been
considered to be a good prognostic factor in some
tumors.3-8 Natural killer (NK) cells in tumor-infiltrating
lymphocytes exhibit a spontaneous cytotoxic capacity
against tumor cells, suggesting that they play a particu-
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The pertinent data for the patients are summarized in Table I.
Patients for whom radical operations had been preoperatively
planned by means of either lobectomy or pneumonectomy
with a hilar and mediastinal lymph node dissection were con-
sidered to have manifested operative indications. None of the
patients received neoadjuvant or adjuvant therapies.
Postoperatively, all patients were followed up for 5 to 10
years, and their outcomes were known.
Immunologic staining. Each resected tissue specimen was
fixed in formalin, embedded in paraffin, and cut into 3-µm
serial sections. Then by means of the monoclonal antibody
for IOT-10 (CD57, NCI immunoglobulin M; Immunotech
SA, Division of Beckman Coulter, Inc, Fullerton, Calif), the
sections were subjected to hematoxylin and eosin staining
and immunohistologic staining for CD57. Monoclonal anti-
body CD57 reacts with cell surface polypeptides present in
mononuclear cells with NK activity.12 Immunohistologic
staining for CD57 was based on the avidin-biotin-peroxidase
complex method and was performed by using a Vestatin Kit
(Vector Laboratories, Inc, Burlingame, Calif). Negative con-
trol sections were treated with nonimmunized mouse
immunoglobulin G as the primary antibody.
Determination of NK cells. Immunologic CD57 staining
was evaluated by means of light microscopy by 2 indepen-
dent observers (K.T. and M.K.) who were unaware of the
patients’ cancer history or disease stage. The total number of
NK cells was counted in 25 intratumoral areas containing
cancerous tissue at a magnification of 200× (area of field,
0.173 mm3), according to the method of Coca and associ-
ates.13 The number of NK cells was determined from the
average of the counts taken by the 2 observers.
Statistical analysis. The mean NK count was chosen as the
cutoff point to divide the patients into 2 groups, and the rela-
tion between groups split by means of mean NK cell counts
and clinicopathologic factors was examined by the χ2 test
with the Fisher correlation. The survival was then compared
between the groups with high and low NK cell numbers, and
the survival was calculated by means of the Kaplan-Meier
method and compared with the results of the log-rank test.
Each prognostic factor was evaluated with regard to survival
in a multivariate analysis by using the Cox proportional haz-
ards regression model. Computer calculations were per-
formed with the StatView statistical package (Abacus
Concepts, Inc, Berkeley, Calif) and a Macintosh System G3
computer (Apple Computer, Cupertino, Calif).
Results
Relationship between NK counts and clinico-
pathologic parameters. In the current study the
majority of CD57+ cells were found in the intratumoral
stroma. The NK cells usually were distributed near the
surface of the tumor (Fig 1, A-D). The NK cells ranged
in number from 3 to 257, with a mean of 32.0 ± 36.4,
and therefore we classified the patients into 2 groups:
the high NK cell count group (n = 53), for which NK
cells numbered greater than 32, and the low NK cell
count group (n = 97), for which NK cells numbered 32
or less. Table II shows the clinicopathologic parameters
for these 2 groups. There were no significant intergroup
differences regarding age, sex, or subtype of pul-
Table I. Patient characteristics
No. of patients
Total 150
Male 83
Female 67
Stage
IA 47
IB 35
IIA 6
IIB 15
IIIA 47
Subtype
Acinar adenocarcinoma 77
Papillary adenocarcinoma 40
Bronchoalveolar adenocarcinoma 13
Solid carcinoma with mucus formation 20
Mean age, y (range) 61 (30-81)
Table II. Relationship between NK cell counts and
various clinicopathologic factors in patients with pul-
monary adenocarcinoma
NK cell numbers
Low (≤32), High (>32),
Variable n = 97 n = 53 P value
Age (y)
≤65 59 29
>65 38 24 .8
Sex
Male 55 28
Female 42 25 .8
T factor
T1 29 28
T2 56 23 .01
T3 12 2
N factor
N0 50 39
N1 9 5 .02
N2 38 9
Stage
IA 23 24
IB 21 14
IIA 3 3 .01
IIB 12 3
IIIA 38 9
Subtype
Acinar 52 25
Papillary 22 18
Bronchoalveolar 10 3 .9
Solid 13 7
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monary adenocarcinoma. As can be seen, NK cells
were significantly related to the T classification, N
classification, and stage (P = .01 for T classification or
stage; P = .02 for N classification).
Relations between NK counts and survival. Of
the 150 tumors staged with TNM classification, 82
were stage I (stage IA and stage IB), 21 were stage II
(stage IIA and stage IIB), and 47 were stage III (stage
IIIA). Patients were classified into 2 groups on the
basis of intratumoral NK cells at the mean cutoff
point. The survival was then compared between the
high NK cell count group and the low NK cell count
group in overall, stage I, stage II, and stage III dis-
ease. Figs 2 and 3 show the difference in survivals
between the high NK cell count group and the low
NK cell count group in the overall and stage I groups
(P = .0002 for the overall group; P = .049 for the
stage I group). Although the 5-year survival in the
high NK cell count group is better than that in the
low NK cell count group in the stage II and stage III
groups, there is not a difference in survival between
the 2 groups (Figs 4 and 5).
Univariate and multivariate analyses. NK cell
infiltration, T classification, and N classification were
analyzed by means of the Cox proportional hazards
regression model (Table III). NK cell infiltration is a
prognostic factor in univariate analysis. Although T
classification and N classification were independent
prognostic factors, NK cell infiltration was not an inde-
pendent prognostic factor in multivariate analysis.
Discussion
There have been some studies detailing the correla-
tion between prognosis and local immune cell infiltra-
tion, and high tumor infiltrating lymphocytes were
associated with improved prognosis for patients with
lung cancer.5,6 Previous studies also suggest a benefi-
cial effect of an enhanced immune cell infiltrate in lung
cancer. One study has immunohistochemically identi-
fied that CD3 (pan–T cell) in excess in lung tumors is
associated with a good prognosis.14 Another study
described the prognostic benefit of tumor-infiltrating
CD45RO (memory T cell) in lung cancer.15 In contrast
to CD3 and CD45RO, the number of intratumoral infil-
Fig 1. A and B show immunohistochemical staining of pulmonary adenocarcinoma with IOT-10 (CD57) mono-
clonal antibody. Positive cells are identified in the stroma of the tumor (arrowhead). Photographs of pulmonary
adenocarcinoma show a negative control, a low level, and a high level of NK-cell infiltration. (A: original magni-
fication 200×; B, C, and D: original magnification 80×.)
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trations by CD8 (T suppressor–cytotoxic cell) had no
statistically significant effect on patient survival.16
Most of the infiltrating lymphocytes consist of T cells,
and NK cells constitute a small portion of the tumor-
infiltrating lymphocytes, which create spontaneous
cell-mediated cytotoxicity in patients with cancer.9 It
was reported that there was a discrepancy between the
degree of lymphocytic infiltration and the number of
infiltrating NK cells.17 The number of NK cells con-
tacting neoplastic cells plays an important role in host
anticancer defense mechanisms.9 To our knowledge,
this is the first report to analyze the prognostic influ-
ence of NK cells in pulmonary adenocarcinoma and the
possible associations between this parameter and other
clinical factors.
NK cells are predominantly large granular lympho-
cytes, the majority of which express CD16 and CD56
cell surface antigens. CD57 is detected on only 30% to
70% of NK cells and T cells,9 and cells stained with
anti-CD57 antibody may have to be called CD57+ cells;
CD57 has been widely used as an NK cell mark-
er.10,12,13,17 We have chosen the monoclonal antibody
IOT-10 (CD57) for identification of NK cells because it
was reported to constantly and accurately immunostain
NK cells on paraffin-embedded specimens.12 In our
study IOT-10+ NK cells were present in all specimens
of pulmonary adenocarcinoma studied, and the majori-
ty of them were found in small numbers dispersed
among tumor cells near the surface of the tumor.
In this study the total number of NK cells was count-
ed in 25 intratumoral areas, and the patients were clas-
sified into 2 groups according to the cutoff point of
mean NK cells per 25 fields at a high magnification.
Previous reports established a value of 25 NK cells per
25 fields as the cutoff point,13,17 although the reason for
this is uncertain. The mean number has been widely
used as the cutoff point to divide the patients into 2
groups. The results of this study showed that high lev-
els of NK cells were found in 35% (53/150) of our
patients with pulmonary adenocarcinoma. A histogram
plot of the NK numbers in patients showed that some
tumors had very high numbers of positive-stained cells
(data not shown). We found that the value of the NK
cell counts was associated with T classification, N clas-
sification, and stage in clinicopathologic factors. Our
results support previous reports in which NK cell infil-
tration was found to correlate with the clinical stage in
gastric carcinoma.17
The TNM staging is an important predictor of sur-
vival. The 5-year survivals were 82% in stage I, 38% in
stage II, and 10% in stage III disease in this study.
Surgical adjuvant chemotherapy has little effect on the
treatment of patients with non–small cell lung carcino-
Fig 2. Overall survival curves of the patients with pulmonary
adenocarcinoma on the basis of NK cell infiltration. A signif-
icant difference was seen between the 2 groups (P = .0002).
Fig 3. Survival curves of the patients with stage I pulmonary
adenocarcinoma on the basis of NK classification. A signifi-
cant difference was seen between the 2 groups (P = .049).
Fig 4. Survival curves of the patients with stage II pulmonary
adenocarcinoma on the basis of NK classification. A signifi-
cant difference was not seen between the 2 groups (P = .3).
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ma. Although there were many patients with lymph
node metastasis, we did not use neoadjuvant or adju-
vant therapies in the current study. T classification, N
classification, and stage were identified as important
prognostic factors in this series of patients with pul-
monary adenocarcinoma. High NK counts were associ-
ated with an improved prognosis with colorectal carci-
noma and gastric carcinoma.13,17 In the current study
we found a positive correlation between NK cell infil-
tration and the surgical outcome in the groups of
patients with all types of pulmonary adenocarcinoma.
When we compared patients in each stage, we found a
positive correlation between NK cell infiltration and
surgical outcome in stage I cancer but not a positive
correlation in stage II and stage III disease. NK cells
are thought to be one of the main effectors responsible
for the antitumor early defense and also to have a
strong influence on the subsequent antitumor immune
response.18 In the current study a possible immune
response by NK cells against the tumor seems to be rel-
evant in a relatively early stage of pulmonary adeno-
carcinoma. As can be seen in Table III, T classification
and N classification were correlated with surgical out-
come by means of univariate analysis. The Cox multi-
variate proportional analysis was performed by means
of T classification, N classification, and NK cell infil-
tration. Although NK cells were a prognostic factor in
the univariate analysis, NK cell infiltration was not
picked up as an independent prognostic factor in the
multivariate analysis. Perhaps this is because NK cell
infiltration correlates with T classification and N clas-
sification. Although NK cells are reported to exhibit a
spontaneous cytotoxic capacity against tumors cells,
this had an influence in only stage I disease in our
study. The lack of statistical significance of NK activi-
ty in multivariate analysis may support the effect of NK
activity.
In conclusion, we found, in this series of patients
with pulmonary adenocarcinoma, that NK counts play
an important role in the regulation of tumor progres-
sion and that NK counts can be a useful marker in
terms of survival of patients with stage I cancer. Further
studies are required to determine the adjuvant use of
immune biologic response modifiers in patients with
low levels of NK cell infiltration, and an increasing
understanding of this field may allow for the future
development of anticancer therapies.
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Notice of correction
In the February 2001 issue of the Journal, in the article by Suehiro and associates titled “Direct Coronary Artery
Perfusion From the Left Ventricle” (2001;121:307-15), an error was made. The wrong copy of Fig 7 was published.
The correct version of Fig 7 is published below, and the correct version of the article is available online at
www.mosby.com/jtcvs.
